- Stem cell therapy for heart failure reduced major CV events and death, not hospitalization Medical Xpress
- Stem Cells Don't Prevent Acute Heart Failure Events MedPage Today
- Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure News-Medical.Net
- Empagliflozin Safe in Acute HF, Improves 'Clinical Benefit' Over Time: EMPULSE TCTMD
- Advanced CKD Doesn't Derail Empagliflozin in EMPEROR-Preserved Medscape
- View Full coverage on Google News
Stem cell therapy for heart failure reduced major CV events and death, not hospitalization – Medical Xpress
ByGoogle News
Nov 15, 2021